Filing Flows › Cavitation Technologies (CVAT) › Q3 FY25
Cavitation Technologies (CVAT) Q3 FY25 earnings results (third quarter fiscal 2025)
10-Q filed May 15, 2025
Cavitation Technologies (CVAT) reported revenue of $122K for the third quarter fiscal 2025 (Q3 FY25), -76% from a year earlier and +61% from the quarter before. Operating margin was -186.9%, net loss $230K (188.5% of revenue).
Cavitation Technologies, Q3 FY25: revenue $122K (-76% year over year), operating margin -186.9%, net loss $230K, operating cash flow −$248K. The chart follows the revenue to costs, profit and cash.
| Q3 FY25 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $122K | +61% | -76% |
| Operating profit | −$228K | — | — |
| Net earnings | −$230K | -140% | — |
| Operating cash flow | −$248K | — | — |
What changed
Revenue was $122K in Q3 FY25, down 76% year over year and up 61% from the previous quarter.
Gross margin was 79.5%, down 19.1 points from a year earlier. Operating costs exceeded revenue by $228K, an operating margin of -186.9%. Operating expenses grew 82% against a revenue fall of 76%. The fastest-growing cost line was Research & development (+367%). The quarter ended with a net loss of $230K, after a profit of $579K the previous quarter.
Operating cash flow was −$248K. Working capital and other items used $18K.
Questions
What was Cavitation Technologies' revenue in the third quarter fiscal 2025?
Cavitation Technologies (CVAT) reported revenue of $122K for the third quarter fiscal 2025 (Q3 FY25), -76% from a year earlier and +61% from the quarter before.
Was Cavitation Technologies profitable in the third quarter fiscal 2025?
Operating loss was $228K (-186.9% of revenue) and net loss $230K.